EMA/777741/2017 Human Medicines Evaluation Division

List of nationally authorised medicinal products Active substance(s): macrogol 4000, macrogol 4000 combinations (systemic use) Procedure No.: PSUSA/00010392/201605

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525 Send a question via our website www.ema.europa.eu/contact

An agency of the European Union

© European Medicines Agency, 2017. Reproduction is authorised provided the source is acknowledged.

Product Name (in authorisation country)

Forlax Junior 4 g, Pulver zur Herstellung einer Lösung zum Einnehmen in einem Beutel Forlax 10 g, Pulver zur Herstellung einer Lösung zum Einnehmen in einem Beutel PAXABEL 10 g polvere per soluzione orale in bustina PAXABEL 10 g polvere per soluzione orale in bustina PAXABEL 4 g polvere per soluzione orale in bustina PAXABEL 4 g polvere per soluzione orale in bustina PAXABEL 4 g polvere per soluzione orale in bustina FORLAX 4g, poudre pour solution buvable en sachet-dose FORLAX 4g, poudre pour solution buvable en sachet-dose FORLAX 4g, poudre pour solution buvable en sachet-dose FORLAX 10 g, poudre pour solution buvable en sachet FORLAX 10 g, poudre pour solution buvable en sachet FORLAX 10 g, poudre pour solution buvable en sachet

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

FR/H/0198/002

BE253635

IPSEN N.V.

BE

FR/H/0198/001

BE259305

IPSEN N.V.

BE

FR/H/0198/001

036003022

IPSEN S.P.A.

IT

FR/H/0198/001

036003034

IPSEN S.P.A.

IT

FR/H/0198/002

036003059

IPSEN S.P.A.

IT

FR/H/0198/002

036003061

IPSEN S.P.A.

IT

FR/H/0198/002

036003073

IPSEN S.P.A.

IT

FR/H/0198/002

34009 360 521 2 3

IPSEN PHARMA

FR

FR/H/0198/002

34009 360 522 9 1

IPSEN PHARMA

FR

FR/H/0198/002

34009 360 523 5 2

IPSEN PHARMA

FR

FR/H/0198/001

34009 338 997.8 3

IPSEN PHARMA

FR

FR/H/0198/001

34009 359 758.2 9

IPSEN PHARMA

FR

FR/H/0198/001

34009 570 314.3 5

IPSEN PHARMA

FR

List of nationally authorised medicinal products EMA/PRAC/4549/2017 Page 2/8

Product Name (in authorisation country)

FORLAX JÚNIOR 4 g pó para solução oral em saquetas FORLAX JÚNIOR 4 g pó para solução oral em saquetas FORLAX JÚNIOR 4 g pó para solução oral em saquetas FORLAX 10 g pó para solução oral em saquetas FORLAX 10 g pó para solução oral em saquetas Dulcolax® M Balance 10 g Pulver zur Herstellung einer Lösung zum Einnehmen Forlax Junior 4 g pulver till oral lösning i dospåse FORLAX 4 g Prášok na perorálny roztok vo vreckách Forlax 10 g poudre pour solution buvable en sachet-dose Forlax Junior 4 g poeder voor drank in een zakje FORLAX 10G PRÁŠOK NA PERORÁLNY ROZTOK VO VRECKÁCH Forlax Junior 4 g poudre pour solution buvable en sachet-dose Forlax 10 g poeder voor drank in een zakje Dulcobalance 10 g, powder for oral solution in sachet Forlax® 10 g Pulver zur Herstellung einer Lösung zum Einnehmen

MRP/DCP Authorisation number

National Authorisation Number

FR/H/0198/002

4728085

FR/H/0198/002

4728184

FR/H/0198/002

4728283

FR/H/0198/001

4728481

FR/H/0198/001

4728580

FR/H/0198/001

61944.01.00

FR/H/0198/002

MAH of product in the member state

IPSEN PORTUGAL PRODUTOS FARMACÊUTICOS, S.A. IPSEN PORTUGAL PRODUTOS FARMACÊUTICOS, S.A. IPSEN PORTUGAL PRODUTOS FARMACÊUTICOS, S.A. IPSEN PORTUGAL PRODUTOS FARMACÊUTICOS, S.A. IPSEN PORTUGAL PRODUTOS FARMACÊUTICOS, S.A.

Member State where product is authorised

PT PT PT PT PT DE

21838

IPSEN PHARMA GMBH INSTITUT PRODUITS SYNTHÈSE (IPSEN) AB

FR/H/0198/002

61/0075/05-S

IPSEN PHARMA

SK

FR/H/0198/001

BE259305

IPSEN N.V.

BE

FR/H/0198/002

BE253635

IPSEN N.V.

BE

FR/H/0198/001

61/0076/05-S

IPSEN PHARMA

SK

FR/H/0198/002

BE253635

IPSEN N.V.

BE

FR/H/0198/001

BE259305

IPSEN N.V.

BE

FR/H/0198/001

PL 34926/0018

IPSEN LTD

UK

FR/H/0198/001

1-24410

IPSEN PHARMA GMBH

AT

SE

Product Name (in authorisation country)

Forlax® 4 g Pulver zur Herstellung einer Lösung zum Einnehmen TANILAS 10g, σκόνη για πόσιμο διάλυμα σε φακελλίσκο TANILAS 4g, σκόνη για πόσιμο διάλυμα σε φακελλίσκο FORLAX 4 g, prášek pro perorální roztok v sáčku FORLAX 10 g, prášek pro perorální roztok v sáčku FORLAX 4 G SUUKAUDSE LAHUSE PULBER FORLAX 10 G SUUKAUDSE LAHUSE PULBER FORLAX 4g, poudre pour solution buvable en sachet-dose FORLAX 10 g, poudre pour solution buvable en sachet Idrolax 10g, powder for oral solution in a sachet PAXABEL 4 g polvere per soluzione orale in bustina PAXABEL 10 g polvere per soluzione orale in bustina FORLAX 4 g pulveris iekšķīgi lietojama šķīduma pagatavošanai FORLAX 10 g pulveris iekšķīgi lietojama šķīduma pagatavošanai Forlax Junior 4 g poudre pour solution buvable en sachet-dose Forlax 10 g poudre pour solution buvable

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

FR/H/0198/002

1-24988

IPSEN PHARMA GMBH

AT

FR/H/0198/001

9218 – 4-2-2011

IPSEN E.P.E.

GR

FR/H/0198/002

9218 – 4-2-2011

IPSEN E.P.E.

GR

FR/H/0198/002

61/147/05-C

IPSEN PHARMA

CZ

FR/H/0198/001

61/148/05-C

IPSEN PHARMA

CZ

FR/H/0198/002

424503

IPSEN PHARMA

EE

FR/H/0198/001

188498

IPSEN PHARMA

EE

FR/H/0198/002

34009 360 520 6 2

IPSEN PHARMA

FR

FR/H/0198/001

34009 359 757.6 8

IPSEN PHARMA

FR

FR/H/0198/001

PA 583/6/1

IPSEN LTD

IE

FR/H/0198/002

036003046

IPSEN S.P.A.

IT

FR/H/0198/001

036003010

IPSEN S.P.A.

IT

FR/H/0198/002

05-0155

IPSEN PHARMA

LV

FR/H/0198/001

05-0156

IPSEN PHARMA

LV

FR/H/0198/002 FR/H/0198/001

2004010034 0182/04/05/0029

IPSEN N.V. IPSEN N.V.

LU LU

Product Name (in authorisation country)

en sachet-dose FORLAX JUNIOR 4 g, poeder voor drank in sachet 4 g FORLAX 10 g, poeder voor drank in sachet 10 g FORLAX JÚNIOR 4 g pó para solução oral em saquetas FORLAX 10 g pó para solução oral em saquetas FORLAX 10 g proszek do sporządzania roztworu doustnego Forlax® 4 g Pulver zur Herstellung einer Lösung zum Einnehmen forlax 4 g milteliai geriamajam tirpalui forlax 4 g milteliai geriamajam tirpalui forlax 4 g milteliai geriamajam tirpalui forlax 4 g milteliai geriamajam tirpalui SELG polvere per soluzione orale SELG polvere per soluzione orale forlax 10 g milteliai geriamajam tirpalui forlax 10 g milteliai geriamajam tirpalui forlax 10 g milteliai geriamajam tirpalui forlax 10 g milteliai geriamajam tirpalui Colofort, Pulver zur Herstellung einer Lösung zum Einnehmen FORTRANS, poudre pour solution buvable en sachet Fortrans, Associação, Pó para solução oral Fortrans prášok na perorálny roztok

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

FR/H/0198/002

RVG 28913

IPSEN FARMACEUTICA B.V.

NL

FR/H/0198/001

RVG 23013

NL

FR/H/0198/002

4727988

FR/H/0198/001

4728382

IPSEN FARMACEUTICA B.V. IPSEN PORTUGAL PRODUTOS FARMACÊUTICOS, S.A. IPSEN PORTUGAL PRODUTOS FARMACÊUTICOS, S.A.

FR/H/0198/001

11783

IPSEN PHARMA

PL

FR/H/0198/002 FR/H/0198/002 FR/H/0198/002 FR/H/0198/002 FR/H/0198/002 not available not available FR/H/0198/001 FR/H/0198/001 FR/H/0198/001 FR/H/0198/001

61944.00.00 LT/1/05/0632/002 LT/1/05/0632/003 LT/1/05/0632/004 LT/1/05/0632/001 028877025 028877013 LT/1/05/0632/006 LT/1/05/0632/007 LT/1/05/0632/008 LT/1/05/0632/005

IPSEN PHARMA GMBH IPSEN PHARMA IPSEN PHARMA IPSEN PHARMA IPSEN PHARMA ALFA WASSERMANN SPA ALFA WASSERMANN SPA IPSEN PHARMA IPSEN PHARMA IPSEN PHARMA IPSEN PHARMA

DE LT LT LT LT IT IT LT LT LT LT

not available

BE 232391

IPSEN N.V.

BE

not available

34009 555 793 1 1

FR

not available not available

4190286 87/0861/94-S

IPSEN PHARMA IPSEN PORTUGAL PRODUTOS FARMACÊUTICOS, S.A. IPSEN PHARMA

PT PT

PT SK

Product Name (in authorisation country)

Colofort poudre pour solution buvable Colofort, poeder voor drank COLOFORT, poeder voor drank in sachet 74 g Colofort, poudre pour solution buvable FORTRANS, prášek pro přípravu perorálního roztoku FORTRANS, poudre pour solution buvable en sachet FORTRANS pulber suukaudse loputuslahuse valmistamiseks ФОРТРАНС прах за перорален разтвор Fortrans pulveris iekšķīgi lietojama šķīduma pagatavošanai FORTRANS, 74 g, proszek do sporządzania roztworu doustnego Fortrans, Associação, Pó para solução oral Fortrans, pulbere pentru soluţie orală FORTRANS, σκόνη για πόσιμο διάλυμα σε φακελλίσκους ISOCOLAN 29,5 g + 2,843 g + 0,843 g + 0,733 g + 0,371 g polvere per soluzione orale ISOCOLAN 29,5 g + 2,843 g + 0,843 g + 0,733 g + 0,371 g polvere per soluzione orale ISOCOLAN 29,5 g + 2,843 g + 0,843 g + 0,733 g + 0,371 g polvere per soluzione orale ISOCOLAN 29,5 g + 2,843 g + 0,843 g +

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

BE 232391 BE 232391

IPSEN N.V. IPSEN N.V.

BE BE

not available not available

RVG 22626 2003040033

IPSEN FARMACEUTICA B.V. IPSEN N.V.

NL LU

not available

61/1281/93-C

IPSEN PHARMA

CZ

not available

34009 328 862 2 7

IPSEN PHARMA

FR

not available not available

218898 20011270

IPSEN PHARMA IPSEN PHARMA

EE BG

not available

95-0265

IPSEN PHARMA

LV

not available

R/7084

PL

not available not available

4190187 1992/2009/01

IPSEN PHARMA IPSEN PORTUGAL PRODUTOS FARMACÊUTICOS, S.A. IPSEN PHARMA

not available

2973/4-4-08

IPSEN E.P.E.

GR

not available

027593019

GIULIANI SPA

IT

not available

027593021

GIULIANI SPA

IT

not available not available

027593033 027593045

GIULIANI SPA GIULIANI SPA

IT IT

not available not available

PT RO

Product Name (in authorisation country)

0,733 g + 0,371 g polvere per soluzione orale ISOCOLAN 14,75 g + 1,422 g + 0,422 g + 0,366 g+ 0,186 g polvere per soluzione orale ISOCOLAN 7,375 g + 0,711 g + 0,211 g + 0,183 g + 0,093 g polvere per soluzione orale fortrans milteliai geriamajam tirpalui Regolint 973,6 mg/g polvere per soluzione orale Regolint 9,7 g polvere per soluzione orale Regolint 9,7 g polvere per soluzione orale MACROGOL BIOGARAN 10 g, poudre pour solution buvable en sachet-dose MACROGOL BIOGARAN 10 g, poudre pour solution buvable en sachet-dose MACROGOL BIOGARAN 10 g, poudre pour solution buvable en sachet-dose MACROGOL 4000 SANDOZ 10 g, poudre pour solution buvable en sachet MACROGOL 4000 SANDOZ 10 g, poudre pour solution buvable en sachet MACROGOL 4000 SANDOZ 10 g, poudre pour solution buvable en sachet FORLAXLIB ADULTE 10 g, poudre pour solution buvable en sachet FORLAXLIB ADULTE 10 g, poudre pour solution buvable en sachet

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

not available

027593060

GIULIANI SPA

IT

not available not available

027593072 LT/1/93/0110/001

GIULIANI SPA IPSEN PHARMA

IT LT

not available

038204032

LABORATORI BALDACCI SPA

IT

not available

038204018

LABORATORI BALDACCI SPA

IT

not available

038204020

LABORATORI BALDACCI SPA

IT

not available

34009 379 505 2 7

IPSEN PHARMA

FR

not available

34009 379 506 9 5

IPSEN PHARMA

FR

not available

34009 570 776 7 9

IPSEN PHARMA

FR

not available

34009 391 346 8 0

IPSEN PHARMA

FR

not available

34009 391 347 4 1

IPSEN PHARMA

FR

not available

34009 577 350 5 0

IPSEN PHARMA

FR

not available

34009 278 357 8 0

IPSEN PHARMA

FR

not available

34009 278 356 1 2

IPSEN PHARMA

FR

Product Name (in authorisation country)

FORLAX 10 g por belsőleges oldathoz Forlax 10 g Pulver zur Herstellung einer Lösung zum Einnehmen FORLAX 10 g FORLAX 10 g FORLAX 10 g FORLAXLIB ADULTE 10 g, poudre pour solution buvable en sachet MACROGOL BIOGARAN 10 g, poudre pour solution buvable en sachet-dose MACROGOL 4000 SANDOZ 10 g, poudre pour solution buvable en sachet FORLAX 10 g por belsőleges oldathoz FORLAX 10 g Forlax 10 g pulver till oral lösning, dospåse PERGIDAL 7,3 g polvere per soluzione orale PERGIDAL bambini 3,6 g polvere per soluzione orale

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

OGYI-T-7512/02

IPSEN PHARMA

HU

not available not available not available not available

41469.00.00 4344/2004/02 4344/2004/03 4344/2004/04

IPSEN PHARMA GMBH IPSEN PHARMA IPSEN PHARMA IPSEN PHARMA

DE RO RO RO

not available

34009 391 348 0 2

IPSEN PHARMA

FR

not available

34009 379 504 6 6

IPSEN PHARMA

FR

not available not available not available

34009 391 345 1 2 OGYI-T-7512/01 4344/2004/01

IPSEN PHARMA IPSEN PHARMA IPSEN PHARMA

FR HU RO

not available

14355

INSTITUT PRODUITS SYNTHÈSE (IPSEN) AB

SE

not available

032920 011

VALEAS S.P.A.

IT

not available

032920 023

VALEAS S.P.A.

IT

not available

macrogol 4000 and combinations (systemic use) - European ...

Send a question via our website www.ema.europa.eu/contact ... Product Name (in authorisation country) .... Colofort, poudre pour solution buvable not available.

190KB Sizes 9 Downloads 343 Views

Recommend Documents

macrogol 3350 - European Medicines Agency - Europa EU
Jan 12, 2017 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name (in authorisation ... not available. 34009 375 323 7 ...

fluorescein (systemic use) PSUSA 00009153 201704 - maintenance
... via our website www.ema.europa.eu/contact. © European Medicines Agency, 2018. Reproduction is authorised provided the source is acknowledged. 11 January 2018. EMA/24042/2018. Human Medicines Evaluation Division. List of nationally authorised med

moxifloxacin (systemic use): CMDh scientific conclusions and grounds ...
Mar 11, 2017 - Taking into account the PRAC Assessment Report on the PSUR(s) for ... 3. Annex II. Amendments to the product information of the nationally ...

amino acid combinations / glucose / triglyceride combinations (e.g. ...
Sep 1, 2017 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name (in authorisation ... for infusion not available.

amino acid combinations / glucose / triglyceride combinations (e.g. ...
Sep 1, 2017 - List of nationally authorised medicinal products. Active substance: amino acid combinations / glucose / triglyceride combinations (e.g. olive oil, ...

moxifloxacin (systemic use): List of nationally authorised medicinal ...
Jan 25, 2017 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name (in authorisation country) ..... not available. 990307.

4000 Entire.pdf
Cross Reference: Interviews with Students #3540. Emergency Spokespersons #4122. Visitor Identification #3311. Legal Reference: IC 33-506(1). Whoops!

Systemic Toxicity and Cardiotoxicity From Local ... - ScienceDirect.com
Central nervous system toxicity from uninten- tionally high blood levels has been a significant concern and risk with local anesthetics since their discovery.

Modeling Contagion and Systemic Risk
May 5, 2015 - from Twitter to the study of the transmission of virus diseases. ...... AAPL. Apple. Technology. 52. LOW. Lowe's Comp. Cons. Disc. 12. BAC.

Systemic sustainability
Dec 10, 2007 - a laptop computer produces 4,000 times its own weight in wastes; the production of one ...... utilising solar energy to drive a materially closed system. ...... of processes provides for backup capacity at the cost of any economies ...

Commander 2016 Partner Combinations - Commanderin
Commander 2016 Partner Combinations cc. Compiled by Alexander Newman (@alexandernewm on Twitter); distributed with permission. 4-color combos ...

[Q231.Book] Download PDF Permutation And Combinations By ...
Page 3 of 7. PERMUTATION AND COMBINATIONS BY RAMESH. CHANDRA PDF. It can be among your early morning readings Permutation And ...

Use of Real World Data in Development Programmes - European ...
6. RCT. Claims data. EHRs. Registries ... CHMP asked to perform a comparison of the treated patients (from both studies) ... patient age (plus or minus 3 years).

European Parliament Condemns Pakistan's Use Of Military Courts ...
Loading… Page 1. Whoops! There was a problem loading more pages. Retrying... Main menu. Displaying European Parliament Condemns Pakistan's Use Of Military Courts And Misuse Of Blasphemy Laws.pdf.

Read PDF Chess: 5334 Problems, Combinations and ...
... r 2 3 3 e s e n d i s c o t h 2 3 2 q u e 2 2 4 M a r s e i l l e t h e 3 6 3 8 3 2 3 t o 1 6 0 5 ..... 5334 Problems, Combinations and Games ,epub file reader for windows .... and Games ,mobile epub Chess: 5334 Problems, Combinations and Games .

chess 5334 problems combinations and games pdf
There was a problem previewing this document. Retrying... Download. Connect more apps... Try one of the apps below to open or edit this item. chess 5334 problems combinations and games pdf. chess 5334 problems combinations and games pdf. Open. Extrac

Incident management plan for medicines for veterinary use - European ...
Dec 7, 2017 - by the European Medicines Agency (EMA or the 'Agency') in 1999. The incident ... Factors that could trigger an incident or a crisis may include newly published data in scientific journals, coverage in the lay .... European Centre for Di

ivermectin (topical use) - European Medicines Agency - Europa EU
Dec 1, 2016 - Send a question via our website www.ema.europa.eu/contact. © European Medicines Agency, 2017. ... Product Name (in authorisation country).

Guidance notes on the use of VeDDRA ... - European Medicines Agency
Jun 15, 2017 - account when analysing adverse event data. In general it is preferable to avoid coding the same or similar clinical signs multiple times (e.g. ...

Reducing Systemic Cybersecurity Risk - OECD
Jan 14, 2011 - views of the OECD or of the governments of its member countries. ...... seeking to punish downloaders of copyright material, against the .... to focus more on the process of analysing risk rather than simply having a long list ... abou

Committee for Medicinal Products for Veterinary Use - European ...
Send a question via our website www.ema.europa.eu/contact. 15 July 2016 ... The Committee started a procedure for Lincocin and its associated names (lincomycin hydrochloride) from Zoetis. .... account the new information available.